ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,523.60
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,876.98
      3.17%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Quince Therapeutics Inc (QNCX) Quote

      Quince Therapeutics Inc

      Quince Therapeutics Inc (QNCX)

      NASDAQ
      0.7857
      0.0057
      (0.73%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      0.7857
      0.00
      ( 0.00% )
      After Hours: 6:55PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.7857
      Bid
      0.7642
      Ask
      0.90
      Volume
      38,524
      0.753 Day's Range 0.82
      0.6331 52 Week Range 1.4301
      Market Cap
      33.954M
      Previous Close
      0.78
      Open
      0.753
      Last Trade
      150
      @
      0.7857
      Last Trade Time
      16:00:01
      Financial Volume
      $ 29,915
      VWAP
      0.776534
      Average Volume (3m)
      99,198
      Shares Outstanding
      43,215,233
      Dividend Yield
      -
      PE Ratio
      -2.69
      Earnings Per Share (EPS)
      -0.73
      Revenue
      -
      Net Profit
      -31.39M

      About Quince Therapeutics Inc

      Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety con... Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety concerns. Quince Therapeutics serves customers in the United States. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      quincetx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Quince Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker QNCX. The last closing price for Quince Therapeutics was $0.78. Over the last year, Quince Therapeutics shares have traded in a share price range of $ 0.6331 to $ 1.4301.

      Quince Therapeutics currently has 43,215,233 shares outstanding. The market capitalization of Quince Therapeutics is $33.71 million. Quince Therapeutics has a price to earnings ratio (PE ratio) of -2.69.

      QNCX Latest News

      More News

      Quince Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of EryDex for the Treatment of Ataxia-Telangiectasia

      Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease...

      June 25 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 07 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      June 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 05 2024
      Edgar (US Regulatory)

      Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System

      Fast Track designation underscores the high unmet medical need, with currently no approved therapeutic treatments for the rare pediatric disease Ataxia-Telangiectasia Quince Therapeutics, Inc...

      June 03 2024
      Business Wire

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 13 2024
      Edgar (US Regulatory)

      Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

      Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease...

      May 13 2024
      Business Wire

      Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference

      Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease...

      May 06 2024
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.03574.760.750.820.72350960.75992567CS
      40.083411.87526697990.70230.870.69577760.75974453CS
      12-0.1343-14.5978260870.921.010.6331991980.81135083CS
      26-0.5143-39.56153846151.31.420.6331842970.96626794CS
      52-0.3543-31.07894736841.141.43010.6331984051.0722499CS
      156-63.7443-98.782426778264.53121.980.54016089289.80478128CS
      260-41.2243-98.129731016442.01121.980.540143020914.93772237CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CGTXCognition Therapeutics Inc
      $ 3.47
      (46.41%)
      		4.6M
      NAMSNewAmsterdam Pharma Company NV
      $ 22.49
      (19.25%)
      		18.82k
      RNAZTransCode Therapeutics Inc
      $ 0.341
      (15.36%)
      		6.61M
      YYGHYY Group Holding Ltd
      $ 0.84
      (14.60%)
      		743
      YIBOPlanet Image International Ltd
      $ 3.32
      (13.89%)
      		56.73k
      VTVTvTv Therapeutics Inc
      $ 13.00
      (-38.68%)
      		33.14k
      CEROCERo Therapeutics Holdings Inc
      $ 0.1669
      (-34.80%)
      		3.51M
      TGLTreasure Global Inc
      $ 1.32
      (-28.65%)
      		53.49k
      LUXHLuxUrban Hotels Inc
      $ 0.1587
      (-16.91%)
      		1.31M
      RGCRegencell Bioscience Holdings Ltd
      $ 10.69
      (-13.02%)
      		14.55k
      SLNASelina Hospitality PLC
      $ 0.0281
      (-6.33%)
      		23.11M
      RNAZTransCode Therapeutics Inc
      $ 0.341
      (15.36%)
      		6.61M
      CGTXCognition Therapeutics Inc
      $ 3.47
      (46.41%)
      		4.6M
      TLTiShares 20 plus Year Treasury Bond
      $ 92.94
      (-0.05%)
      		3.9M
      CEROCERo Therapeutics Holdings Inc
      $ 0.1669
      (-34.80%)
      		3.51M

      QNCX Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      QNCX
      👍️0
      Monksdream Monksdream 5 months ago
      QNCX under $2
      👍️0
      AKATITUS AKATITUS 7 months ago
      Slow climber
      👍️0
      Monksdream Monksdream 10 months ago
      QNCX under $2
      👍️0
      AKATITUS AKATITUS 1 year ago
      Bought some 1.10s
      See what happens
      👍️0
      knrorrel knrorrel 1 year ago
      News https://www.stocktitan.net/news/QNCX/quince-therapeutics-to-acquire-ery-del-sp-a-and-its-phase-3-asset-02yx0yj60e08.html
      👍️0
      AJ Freely AJ Freely 1 year ago
      $QNCX - Up 10% Pre-Market/ Current Price $1.75
      To Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales Opportunity
      👍️0
      AJ Freely AJ Freely 1 year ago
      $QNCX- Up 26% Pre-Market/ Current Price $1.24
      Echo Lake Capital Increase Offer to Acquire Quince Therapeutics
      Increases offer to $1.80 per share + CVR to receive 85% of the future net proceeds of Quince as part of the Lighthouse Pharmaceuticals transaction
      👍️0
      alchemytrader alchemytrader 1 year ago
      Happens. Dirty diluting CEOs
      👍️0
      Backstabbed Backstabbed 1 year ago
      Sorry to hear that
      👍️0
      alchemytrader alchemytrader 1 year ago
      not true. i lost my ass trying to swing PSFE HLBZ FUV. took a terrible loss after finally fiving up. Had i held on i would have lost 90-99% of my money.
      👍️0
      Backstabbed Backstabbed 1 year ago
      all about patience. they all run eventually
      👍️0
      alchemytrader alchemytrader 1 year ago
      congrats
      👍️0
      Backstabbed Backstabbed 1 year ago
      $QNCX - added today!
      👍️0
      Backstabbed Backstabbed 1 year ago
      nice. very low PPS here after it hit a high of $1.75 in PM last week
      👍️0
      Sirpeter Sirpeter 1 year ago
      Hi buddy...added it to watch
      👍️0
      Backstabbed Backstabbed 1 year ago
      $QNCX - News out!!! Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023
      👍️0
      tw0122 tw0122 1 year ago
      $1.33 running again
      👍️0
      saj saj 1 year ago
      Mid 1.3's nice pop on news
      👍️0
      makinezmoney makinezmoney 2 years ago
      $QNCX: Decent bounce move here..... now 0.74


      2 days now back to back....................... it was receding since Summer last ear and now finally going


      On WATCH


      GO $QNCX
      👍️0
      cash4 cash4 2 years ago
      https://www.otcmarkets.com/filing/html?id=15980132&guid=AKk-kW7ZRh7-B3h
      👍️0

      Your Recent History

      NASDAQ
      QNCX
      Quince Therapeutics
      USOTC
      FUUN
      Futurenet (PK)
      LSE
      BIPS
      Invesco Bond Income Plus
      TSXV
      ARC
      ARCpoint
      COIN
      SUIGBP
      SUI Network
      TSXV
      STG
      Stone Gold
      BIT
      O8JRH6
      Morgan Stanley BV
      BIT
      P1LPN9
      BNP Paribas Issuance
      HUOB
      ABTETH
      ArcBlock
      LATK
      SPNDETH
      Spendcoin
      Delayed Upgrade Clock